Koru can be best described as a pharmaceutical center of research in the age of agile, a fast-growing pharmaceutical research and development group, bringing together an expansive pool of high-value experts under one umbrella and offering complex, technologically advanced platforms targeting serious human disease
Koru’s business model fundamentally depends on product innovation to create value by delivering greater customer benefits. Further, sustainable growth and values creation depend on steady R&D productivity with a positive ROI in order to drive future revenues that can be reinvested back into R&D
Koru has a strong focus on “agility” to speed the development of products that better meet customer needs. The attractiveness of agility stems from its potential to increase time spent on value-added work and ensure decisions take days, not months, to enable faster reallocation of resources and to enhance engagement—all of which ultimately translates into dramatically reduced time to market.
Koru established its first center of pharmaceutical research in Auckland, New Zealand in 2017. This laboratory has been very successful in delivering high-value assets to Global partners. Key technology platforms that were added to the facility were OROS, MUPS, SEDDS.
Koru is now expanding its research by establishing research facilities in China and EMA region to increase focus on Lyophilisation, long-acting injectables and further
collaborate with industry partners to offer disease management solutions using platform technologies.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 36 Copsey Place, Auckland,auckland 1348,new Zealand
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- psrnz.com
- Keywords
- Pharmaceutical formulation development, Pharmaceutical Innovation, Osmotic drug delivery system, MUPS, SEDDS, Oncology, Increased bio-availability, novel drug delivery system.
- HQ
- auckland, auckland
Koru Lifescience Limited Questions
Koru Lifescience Limited's website is psrnz.com
Koru Lifescience Limited's LinkedIn profile is https://nz.linkedin.com/company/koru-lifescience-limited
Koru Lifescience Limited has
10 employees.
View email and phone details for 10
employees at Koru Lifescience Limited.
Koru Lifescience Limited's industry is
Pharmaceutical Manufacturing
Koru Lifescience Limited's top competitors are
Viwit Pharmaceuticals,
Range Pharma,
Nam Pharma Sdn Bhd,
Aurisco Pharmaceutical Co.,ltd,
Zhejiang Huahai Pharmaceutical Co., Ltd,
Koru Pharma Co., Ltd.,
Douglas Pharmaceuticals,
Kivipharm Co., Ltd.,
Yiling Pharmaceutical（以岭药业）,
Dec Pharmaceutical.
Koru Lifescience Limited's categories are Pharmaceutical Manufacturing
Koru Lifescience Limited's founding year is 2016
